Adjuvant chemotherapy in dukes c colorectal cancer patients treated in IORS (institute for oncology and radiology of serbia) on a daily basis and in clinical trial: Analysis of mortality rate and toxicity

被引：0
|
作者：
Nikolic, V. [1 ]
Popov, I. [1 ]
机构：
[1] Inst Oncol & Radiol Serbia, Belgrade, Serbia
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：144 / 144
页数：1
相关论文
共 11 条
  • [1] COLORECTAL CANCER IN PATIENTS AGE 40 AND UNDER: A RETROSPECTIVE ANALYSIS OF DATABASE FROM THE INSTITUTE OF ONCOLOGY AND RADIOLOGY OF SERBIA
    Jelena, Spasic
    Neda, Nikolic
    Davorin, Radosavljevic
    ANNALS OF ONCOLOGY, 2014, 25
  • [2] Pathological complete response after neoadjuvant chemotherapy in patients with HER2 low and HER2 0 early breast cancer (eBC) experience from Institute for Oncology and Radiology of Serbia (IORS)
    Djurmez, O.
    Calamac, M.
    Stanic, N.
    Dimitrijevic, M.
    Vukosavljevic, J.
    Serovic, K.
    Oblakovic-Babic, J.
    Minic, I.
    Gavrilovic, D.
    Bozovic-Spasojevic, I.
    BREAST, 2023, 68 : S64 - S64
  • [3] Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy
    Yamada, Hideki
    Iinuma, Hisae
    Watanabe, Toshiaki
    ONCOLOGY REPORTS, 2008, 19 (03) : 729 - 735
  • [4] Toxicity latent classes in chemotherapy-refractory, metastatic colorectal cancer patients treated with anti-epidermal growth factor receptor monoclonal antibody: Latent class analysis of clinical trial data
    Latifovic, Lidija
    Xu, Wei
    Hung, Rayjean
    Liu, Geoffrey
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 65 - 66
  • [5] Quality-Adjusted Time Without Symptoms or Toxicity Analysis of Adjuvant Chemotherapy in Non-Small-Cell Lung Cancer: An Analysis of the National Cancer Institute of Canada Clinical Trials Group JBR.10 Trial
    Jang, Raymond W.
    Le Maitre, Aurelie
    Ding, Keyue
    Winton, Tim
    Bezjak, Andrea
    Seymour, Lesley
    Shepherd, Frances A.
    Leighl, Natasha B.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (26) : 4268 - 4273
  • [6] The impact of virtual oncology care on chemotherapy continuity and clinical outcomes in patients treated for colorectal cancer: A pre-post analysis of the COVID-19 pandemic.
    Phillips, William James
    Leung, Macyn
    Thavorn, Kednapa
    Asmis, Timothy R.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] Clinical outcome of elderly patients with metastatic colorectal cancer treated with FOLFOXIRI versus FOLFIRI: Subgroup analysis of a randomized phase III trial from the Hellenic Oncology Research Group (HORG)
    Vamvakas, L.
    Athanasiadis, A.
    Karampeazis, A.
    Kakolyris, S.
    Polyzos, A.
    Kouroussis, Ch.
    Ziras, N.
    Kalbakis, K.
    Georgoulias, V.
    Souglakos, J.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2010, 76 (01) : 61 - 70
  • [8] Analysis of post-study chemotherapy in patients (pts) enrolled in the X-ACT phase III trial of capecitabine (X) vs. bolus 5-FU/LV as adjuvant therapy for Dukes' C colon cancer: No differences in treatment arms that could influence survival outcome.
    Cassidy, J
    Koralewski, P
    Husseini, F
    Twelves, C
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 267S - 267S
  • [9] ESTIMATING THE HEALTH STATE UTILITY OF PATIENTS WITH HER2-GBRCA+ METASTATIC BREAST CANCER TREATED WITH OLAPARIB OR CHEMOTHERAPY VIA A MAPPING ANALYSIS OF EORTC QLQ-C30 DATA COLLECTED IN THE OLYMPIAD CLINICAL TRIAL
    Robson, M.
    Hettle, R.
    Degboe, A.
    Saunders, O.
    Cain, T.
    Kilvert, H.
    Johnson, H.
    VALUE IN HEALTH, 2018, 21 : S12 - S12
  • [10] The effect of short term neo-adjuvant androgen deprivation on erectile function in patients treated with external beam radiotherapy for localised prostate cancer: An analysis of the 4-versus 8-month randomised trial (Irish Clinical Oncology Research Group 97-01)
    Daly, Patricia E.
    Dunne, Mary T.
    O'Shea, Carmel M.
    Finn, Marie A.
    Armstrong, John G.
    RADIOTHERAPY AND ONCOLOGY, 2012, 104 (01) : 96 - 102
12